The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer
Clinical trial NCT06477055 · COMPLETED
Trial details
- NCT number
- NCT06477055
- Sponsor
- Hunan Province Tumor Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-02
- Primary completion
- 2026-04-21
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.